Hong Kong Diversified Financial Stock News

The market wasn't impressed with the soft earnings from BOC Aviation Limited ( HKG:2588 ) recently. We did some...

Nongfu Spring Co., Ltd. ( HKG:9633 ) just released its yearly report and things are looking bullish. The company beat...

In the face of global market volatility and geopolitical tensions, Asian markets have shown resilience amid rising energy prices and economic uncertainties. With central banks signaling caution due to inflation risks, investors are increasingly turning their attention to growth companies with high insider ownership, which can often indicate strong confidence in a company's potential amidst challenging conditions.

Duality Biotherapeutics, Inc. ( HKG:9606 ) shareholders are probably feeling a little disappointed, since its shares...

There's been a notable change in appetite for Xiaomi Corporation ( HKG:1810 ) shares in the week since its yearly...

As you might know, Henderson Land Development Company Limited ( HKG:12 ) last week released its latest annual, and...

Beijing Enterprises Environment Group (SEHK:154) just posted its FY 2025 first half numbers, reporting revenue of C¥722.4 million and basic EPS of C¥0.085, with net income excluding extra items at C¥127.1 million. Trailing 12 month revenue was C¥1.4 billion and basic EPS was C¥0.155. The company reported revenue of C¥803.2 million and basic EPS of C¥0.094 in 1H FY 2024, followed by revenue of C¥860.9 million and EPS of C¥0.100 in 2H FY 2024. Trailing 12 month net income excluding extra items...

Investors may be wondering whether PetroChina's recent performance still leaves room for value, or if the easier gains are already behind it. The stock last closed at HK$10.88, with returns of 1.4% over 7 days, 13.8% over 30 days, 27.7% year to date and 85.3% over 1 year. This performance may have shifted how investors view its potential and risk. Recent coverage has focused on PetroChina's share price strength and its role in the wider energy sector. This gives investors more reasons to...

Keck Seng Investments (Hong Kong) (SEHK:184) has opened FY 2025 with first half revenue of HK$772.6 million and basic EPS of HK$0.03, setting a more muted tone against a backdrop of previously higher earnings. Over recent periods, the company has reported revenue of HK$809.0 million and EPS of HK$0.26 in 1H 2024, followed by revenue of HK$883.0 million and EPS of HK$0.50 in 2H 2024, before arriving at the current 1H 2025 levels. With a 15.9% net profit margin over the last 12 months and a...

Guotai Junan International Holdings (SEHK:1788) has reported its FY 2025 first half results with revenue of HK$1,638.1 million and basic EPS of HK$0.058, set against a trailing twelve month backdrop of HK$3.8 billion in revenue and EPS of HK$0.141, where earnings over the last year rose 286.8%. Over recent periods the company has seen revenue move from HK$1,067.8 million and EPS of HK$0.020 in 1H 2024 to HK$1,076.0 million and EPS of HK$0.016 in 2H 2024, before reaching the latest HK$1,638.1...

Robosense Technology (SEHK:2498) closed FY 2025 with fourth quarter revenue of C¥750.7 million and basic EPS of C¥0.24, while the trailing twelve months showed revenue of C¥1.9 billion and a basic EPS loss of C¥0.32. Over recent quarters, revenue has moved from C¥513.9 million in Q4 FY 2024 to C¥750.7 million in Q4 FY 2025, with quarterly EPS shifting from a loss of C¥0.30 to a profit of C¥0.24. For investors, the mix of higher quarterly revenue, a swing to quarterly profitability, and an...

Genertec Universal Medical Group (SEHK:2666) has reported FY 2025 first half revenue of CNY 7.5b and basic EPS of CNY 0.65. Trailing twelve month EPS stands at CNY 1.13 and revenue at CNY 14.9b, helping frame the current earnings picture. The company’s revenue has moved from CNY 6.4b in 2024 H1 to CNY 6.9b in 2024 H2 and then to CNY 7.5b in 2025 H1. Net income excluding extra items tracked from CNY 1,137.2m to CNY 894.5m and then CNY 1,228.1m, setting up a results season where investors are...

China Resources Pharmaceutical Group (SEHK:3320) FY 2025 Earnings Snapshot China Resources Pharmaceutical Group (SEHK:3320) has posted its latest FY 2025 numbers with first half revenue of about C¥131.9b and basic EPS of C¥0.33, set against trailing twelve month EPS of C¥0.64. The company has seen revenue move from roughly C¥128.6b in 1H 2024 to C¥131.9b in 1H 2025, while basic EPS shifted from C¥0.41 in 1H 2024 and C¥0.12 in 2H 2024 to C¥0.33 in the latest half. This sets up a discussion...

Bank of Chongqing (SEHK:1963) has wrapped up FY 2025 with fourth quarter revenue of C¥2,287.3 million and basic EPS of C¥0.18, while trailing twelve month revenue came in at C¥10,887.8 million with EPS of C¥1.53. Over the past year, revenue has moved from C¥10,074.5 million to C¥10,887.8 million on a trailing basis, alongside an 18% rise in earnings and a net profit margin that lifted from 47.6% to 51.9%. This points to a business that is converting more of its top line into profit. For...

AK Medical Holdings (SEHK:1789) has reported FY 2025 first half revenue of C¥694.2 million and basic EPS of C¥0.144. The trailing twelve month figures show C¥1.48 billion of revenue and C¥0.304 in EPS, alongside a 23.8% earnings growth rate and revenue growth of about 14.9% over the past year. Over recent reporting periods, the company has seen revenue move from C¥657.1 million in 1H 2024 to C¥689.3 million in 2H 2024 and C¥694.2 million in 1H 2025. Basic EPS shifted from C¥0.125 to C¥0.121...

COSCO SHIPPING International (Hong Kong) (SEHK:517) has laid out a clean set of FY 2025 numbers, with first half revenue at HK$1,934 million and basic EPS of HK$0.33 helping lift trailing twelve month EPS to HK$0.53 on revenue of HK$3.7 billion. Over the last three reported halves, revenue has moved from HK$1,753 million in 1H FY 2024 to HK$1,874 million in 2H FY 2024 and then to HK$1,934 million in 1H FY 2025. Basic EPS tracked HK$0.26, HK$0.22 and HK$0.33 across the same periods, setting up...

CSPC Pharmaceutical Group (SEHK:1093) has wrapped up FY 2025 with fourth quarter revenue of C¥6.1b and basic EPS of C¥0.033, alongside full year trailing revenue of C¥26.0b and basic EPS of C¥0.340 that frame the latest set of numbers. Over recent periods, quarterly revenue has ranged from C¥6.1b to C¥7.0b, while basic EPS has moved between C¥0.033 and C¥0.129. This gives investors a clear view of how the top and bottom line are tracking through the year. With a reported net profit margin of...

Pop Mart International Group (SEHK:9992) has reported FY 2025 results with second half revenue of C¥23.2b and basic EPS of C¥6.16, while trailing 12 month revenue stands at C¥37.1b and EPS at C¥9.61, set against trailing 12 month earnings growth of about 308.8% and a net margin of 34.4%. Over recent periods, the company has seen revenue move from C¥8.5b and EPS of C¥1.66 in 2024 H2 to C¥13.9b and EPS of C¥3.44 in 2025 H1, then to C¥23.2b and EPS of C¥6.16 in 2025 H2. Margins are now a key...

Setting the Scene: Suzhou Ribo Life Science's Latest Numbers Suzhou Ribo Life Science (SEHK:6938) has posted another loss for FY 2025, with first half revenue of ¥103.8 million and a basic EPS loss of ¥0.68, while trailing twelve month revenue sits at ¥148.5 million against a TTM EPS loss of ¥2.11. Looking back, revenue has moved from ¥66.3 million in 1H 2024 to ¥76.3 million in 2H 2024 and then to ¥103.8 million in 1H 2025, while basic EPS losses over these halves have gone from ¥1.07 to...

Bank of China has exercised its redemption right on a RMB 15b tranche of Tier 2 capital bonds issued in 2021. The full redemption affects the bank's mix of regulatory capital and could influence its future funding costs. This move reflects an active approach to managing its capital structure and overall financial flexibility. For investors watching Bank of China (SEHK:3988), this capital action comes with the shares trading at HK$4.84 and showing a 6.8% return year to date and an 11.0%...

Kuaishou Technology (SEHK:1024) has wrapped up FY 2025 with fourth quarter revenue of C¥39.6b and basic EPS of C¥1.22, against trailing 12 month revenue of C¥142.8b and EPS of C¥4.35 that came with 21.4% earnings growth over the prior year. Over recent periods, revenue has moved from C¥35.4b in Q4 2024 to C¥39.6b in Q4 2025, while quarterly basic EPS has shifted from C¥0.93 to C¥1.22, presenting a set of results where a 13% net profit margin and improving earnings trends are front and centre...

China Life Insurance (SEHK:2628) has wrapped up FY 2025 with a mixed final quarter, reporting Q4 revenue of CNY 39.3b and a basic EPS loss of CNY 0.48, set against trailing 12 month EPS of CNY 5.45 on revenue of CNY 352.1b. Investors are weighing recent 44.1% earnings growth and a net profit margin of 43.8% against forecasts of an 8.1% annual earnings decline over the next three years. Over recent periods the company has seen quarterly revenue move from CNY 58.9b in Q4 2024 to CNY 64.3b in Q1...

ANTA Sports Products (SEHK:2020) has just posted its FY 2025 numbers, with second half revenue of C¥41.7b, basic EPS of C¥2.36 and net income of C¥6.6b, set against a trailing 12 month picture showing C¥80.2b in revenue, basic EPS of C¥4.89 and net income of C¥13.6b as margins eased from 22% to 16.9%. The company has seen revenue move from C¥37.1b and basic EPS of C¥2.81 in the second half of 2024 to C¥41.7b and C¥2.36 in the second half of 2025. Over the same period, trailing 12 month EPS...

Sunac Services Holdings FY 2025 Earnings Snapshot Sunac Services Holdings (SEHK:1516) has reported its FY 2025 numbers with first half revenue of CN¥3,546.6 million and basic EPS of CN¥0.04, while trailing twelve month revenue sits at CN¥6,816.2 million and EPS at CN¥0.07 as the business moves away from prior losses. Over the last three reported half year periods, revenue has held close to the CN¥3,480 million to CN¥3,550 million range, while EPS has swung from a loss of CN¥0.15 in 1H 2024 to...